Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Reference number: TA275
Published: 27 February 2013
Last updated: 02 July 2021

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Professor Gregory Lip - appendix D clinical specialist statement

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Professor Gregory Lip - appendix D clinical specialist statement

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Professor Gregory Lip - appendix D clinical specialist statement
23 January 2013
(97.7 Kb 28 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 21 January 2013